[THE INVESTOR] On Oct. 21, CTC BIO (060590) fell 2.32% to 9,690 won (US$ 8.53). It had declined 10.37% through the past month. Standard deviation, the risk index for stock price, was 2% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of CTC BIO was around the average of that of its peer group, but the investment return for 1 month was at an absolutely low level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -5.1%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -4.6, and thus it is hard to say that the industrial comparison performance was positive.

From Oct. 17, institutions have been continuously selling CTC BIO during the past 4 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have sold 26,543 shares and Institutions have sold 183,711 shares with a selling trend. However, during the same period, individuals have bought 210,254 shares with an increasing position.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.